Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2012
12/18/2012US8333958 HSA-free formulations of interferon-Beta
12/18/2012CA2716966C Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
12/18/2012CA2702933C Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
12/18/2012CA2671776C Gal3 receptor antagonists for the treatment of depression
12/18/2012CA2599971C Use of neuronal precursor cells for treatment of central nervous system lesions
12/18/2012CA2563674C .alpha.-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
12/18/2012CA2563575C Enantiomerically pure hexahydropyrrolocyclopentapyridine derivatives
12/18/2012CA2557792C Novel use for pde5 inhibitors
12/18/2012CA2392545C Pharmaceutical formulations for thyroid hormones
12/13/2012WO2012170917A2 Reduction of microglia-mediated neurotoxicity by kv1.3 inhibition
12/13/2012WO2012170899A2 Pharmaceutical compositions containing proteases and methods for the treatment of lysosomal storage diseases
12/13/2012WO2012170839A2 Treatment of neuroinflammatory disease with selective cox1 inhibitors
12/13/2012WO2012170452A2 Compositions and methods for treating neurodegenerative diseases
12/13/2012WO2012169649A1 Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
12/13/2012WO2012169571A1 Novel n-(pyridin-2-yl)alkanamide derivative and ship2 inhibitor containing same as an active ingredient
12/13/2012WO2012169417A1 Film-like anesthetic drug
12/13/2012WO2012168817A1 Pyrazolo[3,4-d]pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors
12/13/2012WO2012168710A1 Hydantoin derivates as kv3 inhibitors
12/13/2012WO2012168665A1 Novel agomelatine cocrystals, method for preparing same, and pharmaceutical compositions containing same
12/13/2012WO2012168664A1 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, method for preparing same and pharmaceutical compositions that contain same
12/13/2012WO2012168657A1 Process for synthesis and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide hydrochloride, in addition to the associated free base and the pharmaceutical compositions containing same
12/13/2012WO2012168411A1 Use of carpipramine in the treatment of psychiatric and developmental disorders in children and adolescents
12/13/2012WO2012168368A1 Benzoquinolizidine derivatives, method for preparing same, and therapeutic uses thereof
12/13/2012WO2012168265A1 Substituted benzamide derivatives
12/13/2012WO2012168260A1 Pyrazole derivatives
12/13/2012WO2012168245A1 Chicory for prevention and treatment of neurodegeneration
12/13/2012WO2012168175A1 [1,3]oxazines
12/13/2012WO2012168164A1 Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors
12/13/2012WO2012158892A9 A method of treating apraxia of speech in children
12/13/2012WO2012145234A3 Cyclopropyl derivatives and methods of use
12/13/2012WO2012138254A3 Pharmacologically active 4,4'-biphenylamide derivatives and drugs based thereon
12/13/2012WO2012131412A3 Pharmaceutical composition containing no, process for the preparation and use thereof
12/13/2012WO2012117075A3 Treatment of cerebral ischemia
12/13/2012WO2012115439A3 Composition comprising expression or activity regulators of akap12 for treating central nerve system diseases
12/13/2012US20120316380 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316354 Pasteurisation process for microbial cells and microbial oil
12/13/2012US20120316247 Prevention and treatment of post-operative cognitive dysfunction (pocd)
12/13/2012US20120316245 Co-crystals of agomelatine, a process for there preparation and pharmaceutical compositions containing them
12/13/2012US20120316244 Pharmaceutical Formulations of Modafinil
12/13/2012US20120316238 novel polymomorph of desvenlafaxine benzoate
12/13/2012US20120316223 MODULATION OF pre-mRNA USING SPLICE MODULATING OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS IN THE TREATMENT OF DISEASE
12/13/2012US20120316214 Synthesis process, and crystalline form of 4-benzamide hydrochloride and pharmaceutical compositions containing it
12/13/2012US20120316212 Amino alcohol derivatives and their therapeutic activities
12/13/2012US20120316202 Compounds which have activity at M1 receptor and their uses in medicine
12/13/2012US20120316201 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/13/2012US20120316200 Pyridone derivatives
12/13/2012US20120316198 Hydrazone and diacyl hydrazine compounds and methods of use
12/13/2012US20120316196 Compounds Which Have Activity at M1 Receptor and Their Uses in Medicine
12/13/2012US20120316195 Aryl-pyridine derivatives as aldosterone synthase inhibitors
12/13/2012US20120316194 Apoptosis signal-regulating kinase 1 inhibitors
12/13/2012US20120316193 Proteostasis regulators
12/13/2012US20120316189 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients diagnosed or undiagnosed respiratory illness
12/13/2012US20120316188 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors
12/13/2012US20120316186 Deazapurines useful as inhibitors of janus kinases
12/13/2012US20120316182 Compounds that modulate intracellular calcium
12/13/2012US20120316181 Hexahydro-1h-4,7-methanoisoindole-1,3-dione compounds
12/13/2012US20120316180 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120316179 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120316174 Disubstituted phthalazine hedgehog pathway antagonists
12/13/2012US20120316173 Compounds which modulate the cb2 receptor
12/13/2012US20120316172 Pyrazole derivatives
12/13/2012US20120316170 Imidazole Derivative
12/13/2012US20120316169 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
12/13/2012US20120316168 Quinolone compound and pharmaceutical composition
12/13/2012US20120316166 Hetarylaminonaphthyridines
12/13/2012US20120316165 Substituted benzamide derivatives
12/13/2012US20120316163 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316159 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
12/13/2012US20120316155 Imidazole-2,4-Dione Inhibitors of Casein Kinase 1
12/13/2012US20120316153 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
12/13/2012US20120316152 Substituted isoquinolineand isoquinolinone derivatives
12/13/2012US20120316149 Heterocyclic sulfonamide derivatives
12/13/2012US20120316148 Compositions and Methods for Modulating a Kinase
12/13/2012US20120316146 Anaesthetic formulation
12/13/2012US20120316141 Method for providing neuroprotection from spinal muscular atrophy
12/13/2012US20120316140 Analgesic composition and method of making the same
12/13/2012US20120316139 Anti-inflammatory compounds and uses thereof
12/13/2012US20120316120 Fluorine containing compounds and methods of use thereof
12/13/2012US20120316109 Polymer-conjugated glycosylated neublastin
12/13/2012US20120316101 Peptides for targeting apoptotic cells and uses thereof
12/13/2012US20120316100 Therapeutic Use of Peptide Inhibitors of NADPH Oxidase; Aerosolization as a Delivery Mechanism
12/13/2012US20120315336 Injectable nanoparticulate olanzapine formulations
12/13/2012US20120315331 Pharmaceutical composition for the treatment of acute disorders
12/13/2012US20120315330 Pharmaceutical composition for the treatment of acute disorders
12/13/2012US20120315326 Multiparticulate l-carnitine compositions and related methods
12/13/2012US20120315324 Exosomal compositions and methods for the treatment of disease
12/13/2012US20120315322 Nanoparticle mediated gene therapy and therapeutic products for alzheimers
12/13/2012US20120315321 Immunological methods and compositions for the treatment of alzheimer's disease
12/13/2012US20120315302 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120315298 Local treatment of neurofibromas
12/13/2012US20120315297 Treatment of Psychological Trauma
12/13/2012US20120315285 Antibody Formulation
12/13/2012US20120315284 Composition for enhancing trail sensitivity comprising inhibitors for expression or activity of tip41 as a target gene of trail sensitizer
12/13/2012US20120315283 Methods of promoting tissue growth and tissue regeneration
12/13/2012US20120315282 Antibodies Specific for TGF-Beta
12/13/2012US20120315271 Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
12/13/2012US20120315266 Detecting complement activation
12/13/2012US20120315262 Stabilized open form transglutaminase as a diagnostic indictor for autoimmune diseases
12/13/2012US20120315244 Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products
12/13/2012CA2838818A1 Methods of treatment for retinal diseases
1 ... 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 ... 1833